TMCnet News
Global Genetic Diseases, Cancer, Forensic & Paternity Molecular Diagnostic Testing Markets Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Affymetrix, Biokit, Dia - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/gql6nb/20162020_world) has announced the addition of the "2016-2020 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape" report to their offering. This new seven-country study contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Key Topics Covered:
In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Contains 570 pages and 42 tables Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/gql6nb/20162020_world View source version on businesswire.com: http://www.businesswire.com/news/home/20160325005123/en/ |